Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > zacks:c8202915a094b:0-bridgebio-q2-sales-jump-120-as-attruby-drives-commercial-momentum

BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum

2+ week, 4+ day ago   (621+ words) BridgeBio Pharma BBIO entered the second half of 2026 with Attruby doing most of the commercial heavy lifting. Second-quarter revenues rose 120% year over year and topped the Zacks Consensus Estimate, but the company still posted a wider-than-expected loss as development and…...